Hommes DW - Search Results

1

NOD2 in Crohn's disease--loss or gain of function mutations?

Zelinkova Z, Stokkers P, Hommes DW. Zelinkova Z, et al. Among authors: hommes dw. Neth J Med. 2005 Sep;63(8):286-7. Neth J Med. 2005. PMID: 16186636 Free article. No abstract available.

2

Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease.

de Ridder L, Weersma RK, Dijkstra G, van der Steege G, Benninga MA, Nolte IM, Taminiau JA, Hommes DW, Stokkers PC. de Ridder L, et al. Among authors: hommes dw. Inflamm Bowel Dis. 2007 Sep;13(9):1083-92. doi: 10.1002/ibd.20171. Inflamm Bowel Dis. 2007. PMID: 17476680

3

Muramyl dipeptide-induced differential gene expression in NOD2 mutant and wild-type Crohn's disease patient-derived dendritic cells.

Zelinkova Z, van Beelen AJ, de Kort F, Moerland PD, Ver Loren van Themaat E, te Velde AA, van Deventer SJ, de Jong EC, Hommes DW. Zelinkova Z, et al. Among authors: hommes dw. Inflamm Bowel Dis. 2008 Feb;14(2):186-94. doi: 10.1002/ibd.20308. Inflamm Bowel Dis. 2008. PMID: 17941075

4

Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.

Weersma RK, Stokkers PC, van Bodegraven AA, van Hogezand RA, Verspaget HW, de Jong DJ, van der Woude CJ, Oldenburg B, Linskens RK, Festen EA, van der Steege G, Hommes DW, Crusius JB, Wijmenga C, Nolte IM, Dijkstra G; Dutch Initiative on Crohn and Colitis (ICC). Weersma RK, et al. Among authors: hommes dw. Gut. 2009 Mar;58(3):388-95. doi: 10.1136/gut.2007.144865. Epub 2008 Sep 29. Gut. 2009. PMID: 18824555

5

Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease.

Hommes DW, Duijvestein M, Zelinkova Z, Stokkers PC, Ley MH, Stoker J, Voermans C, van Oers MH, Kersten MJ. Hommes DW, et al. J Crohns Colitis. 2011 Dec;5(6):543-9. doi: 10.1016/j.crohns.2011.05.004. Epub 2011 Jun 12. J Crohns Colitis. 2011. PMID: 22115372

6

Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells.

van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW, Zaat SA, Kapsenberg ML, de Jong EC. van Beelen AJ, et al. Among authors: hommes dw. Immunity. 2007 Oct;27(4):660-9. doi: 10.1016/j.immuni.2007.08.013. Epub 2007 Oct 4. Immunity. 2007. PMID: 17919942 Free article.

7

Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease.

Fransen K, Visschedijk MC, van Sommeren S, Fu JY, Franke L, Festen EA, Stokkers PC, van Bodegraven AA, Crusius JB, Hommes DW, Zanen P, de Jong DJ, Wijmenga C, van Diemen CC, Weersma RK. Fransen K, et al. Among authors: hommes dw. Hum Mol Genet. 2010 Sep 1;19(17):3482-8. doi: 10.1093/hmg/ddq264. Epub 2010 Jul 3. Hum Mol Genet. 2010. PMID: 20601676

8

[Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis].

Minnee RC, Stokkers P, Riemens SC, Hommes DW. Minnee RC, et al. Among authors: hommes dw. Ned Tijdschr Geneeskd. 2005 Oct 8;149(41):2290-5. Ned Tijdschr Geneeskd. 2005. PMID: 16240855 Dutch.

9

New cytokine therapeutics for inflammatory bowel disease.

Stokkers PC, Hommes DW. Stokkers PC, et al. Among authors: hommes dw. Cytokine. 2004 Nov 21-Dec 7;28(4-5):167-73. doi: 10.1016/j.cyto.2004.07.012. Cytokine. 2004. PMID: 15588691 Review.

10

Novel biological therapies for inflammatory bowel disease.

Stokkers PC, Hommes DW. Stokkers PC, et al. Among authors: hommes dw. Curr Treat Options Gastroenterol. 2006 Jun;9(3):201-10. doi: 10.1007/s11938-006-0039-y. Curr Treat Options Gastroenterol. 2006. PMID: 16901384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page